ArticleMolecular biomedicine2026

RPRD1A drives lenvatinib resistance in hepatocellular carcinoma via the ITGA5-FAK signaling axis.

Xiaomeng Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.